Sizzling Stocks: Facebook Inc (NASDAQ:FB), Frontier Communications Corporation (NASDAQ:FTR), Franklin Street Properties Corp. (NYSEMKT:FSP), Cardinal Financial Corp. (NASDAQ:CFNL), Randgold Resources Limited (NASDAQ:GOLD)

Facebook Inc (NASDAQ:FB) will announce its financial results for the fourth quarter of 2014 and the full year after market close Wednesday, Jan. 28, the social network announced Tuesday. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 24.50% and weekly performance is -3.89%. On last trading day company shares ended up $76.15. Facebook Inc (NASDAQ:FB) distance from 50-day simple moving average … Continue reading Sizzling Stocks: Facebook Inc (NASDAQ:FB), Frontier Communications Corporation (NASDAQ:FTR), Franklin Street Properties Corp. (NYSEMKT:FSP), Cardinal Financial Corp. (NASDAQ:CFNL), Randgold Resources Limited (NASDAQ:GOLD)

Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

On 7 AUG OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced second quarter 2014 financial results. Revenue for the three and six months ended June 30, 2014 was $4.9 million and $16.7 million, respectively.  This compares with $6.3 million and $11.4 million, respectively, in the same periods in 2013. Revenue earned in the second quarter of 2014 consists of reimbursable clinical trial, manufacturing and preclinical costs incurred by … Continue reading Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Novartis AG (ADR) (NYSE:NVS) announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent Meningococcal Group B Vaccine [recombinant, adsorbed]) to help protect against invasive meningococcal disease caused by serogroup B (meningitis B) in adolescents and young adults from 10 years through 25 years of age. Novartis AG … Continue reading Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)